Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

(2017) Fergus J. Couch et al.   JAMA Oncology

No evidence that protein truncating variants inBRIP1are associated with breast cancer risk: implications for gene panel testing

(2016) Douglas F Easton et al.   JOURNAL OF MEDICAL GENETICS

Multigene testing of moderate-risk genes: be mindful of the missense

(2016) E L Young et al.   JOURNAL OF MEDICAL GENETICS

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer

(2016) Haeyoung Kim et al.   Cancer Research and Treatment

Beyond BRCA: New hereditary breast cancer susceptibility genes

(2015) P. Economopoulou et al.   CANCER TREATMENT REVIEWS

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

(2015) Lisa R. Susswein et al.   GENETICS IN MEDICINE

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer

(2015) Yosuke Hirotsu et al.   Molecular Genetics & Genomic Medicine

Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel

(2014) Nadine Tung et al.   CANCER

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer

(2014) Kara N. Maxwell et al.   GENETICS IN MEDICINE

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

(2014) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

A robust model for read count data in exome sequencing experiments and implications for copy number variant calling

(2012) Vincent Plagnol et al.   BIOINFORMATICS

A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women

(2011) Yin Liu et al.   HUMAN MUTATION

Role of mammalian Mre11 in classical and alternative nonhomologous end joining

(2009) Anyong Xie et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: Not present in the Chinese familial breast cancer population

(2008) Wang Chen et al.   ADVANCES IN THERAPY

The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation

(2008) Doo Ho Choi et al.   BREAST CANCER RESEARCH AND TREATMENT

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

(2008) S. Zhang et al.   CANCER RESEARCH